EuroPharma, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Green Bay WI United States (1982)
Status: No NME R&D (1982)

Organization Overview

First Clinical Trial
2015
NCT02390349
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Euro-Pharm | EuroPharma, Inc. | EURO-PHARM International Canada inc. | EURO-PHARM International Canada, Inc.

Active Ingredients

Drugs in Phase 4 Trials (1)

ginseng (3 trials)

Drugs in Phase 3 Trials (1)

vitamin d3 (3 trials)

Drugs in Phase 2 Trials (4)

black cohosh (1 trial)

curcumin (2 trials)

echinacea (1 trial)

rhodiola (1 trial)

Drugs in Phase 1 Trials (2)

berberine (1 trial)

cyclodextrin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Sickle Cell (Phase 3)

Anxiety Disorders (Phase 2)

Asthma (Phase 3)

Cholangitis (Phase 2)

Cholangitis, Sclerosing (Phase 2)

Stress, Psychological (Phase 2)

Vitamin D Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 8